Department of Medical Chemistry, Medical University of Białystok, ul. Mickiewicza 2, Białystok 15-222, Poland.
Biomed Pharmacother. 2024 May;174:116619. doi: 10.1016/j.biopha.2024.116619. Epub 2024 Apr 20.
Glycosylation of cancerous epithelial MUC1 protein is specifically altered in comparison to that which is presented by healthy cells. One of such changes is appearing tumor-associated carbohydrate antigens (TACAs) which are rare in normal tissues and are highly correlated with poor clinical outcomes and cancer progression. This review summarizes and describes the role of Tn, T antigens, their sialylated forms as well as fucosylated Lewis epitopes in different aspects of tumor development, progression, and metastasis. Finally, applications of MUC1 glycan epitopes as potential targets for therapeutic strategy of cancers are notified. One of the novelties of this review is presentation of TACAs as inherently connected with MUC1 mucin.
与健康细胞相比,癌变上皮细胞 MUC1 蛋白的糖基化会发生特定改变。其中一种改变是出现肿瘤相关碳水化合物抗原(TACA),这些抗原在正常组织中很少见,与不良临床结局和癌症进展高度相关。本综述总结并描述了 Tn、T 抗原及其唾液酸化形式以及岩藻糖基化 Lewis 表位在肿瘤发生、发展和转移的不同方面的作用。最后,还通知了 MUC1 糖基化表位作为癌症治疗策略潜在靶点的应用。本综述的新颖之处之一是将 TACA 呈现为与 MUC1 粘蛋白固有相关。